Read the bio on Dr Danishefsky, on the Scientific Advisory board for CTIX since 2009, and just recently gave CTIX "inside" position on new compound. This is the kind of quality person that gives me long-term hope in Kevetrin and CTIX.
Dr. Samuel J. Danishefsky, Ph.D., co-founded Memorial Sloan-Kettering Cancer research Center and serves as its Chairman. Dr. Danishefsky has been Director of the Laboratory for Cancer Research Bioorganic Chemistry at Memorial Sloan-Kettering Cancer Center since 1991. He serves as Professor of Chemistry at Columbia University in 1993, where he conducts research. He is one of the world's pre-eminent medicinal chemists, recognized in particular for his work on the synthesis of anti-tumor agents derived from natural products. He serves as a Professor and as a Director of Laboratory at Bioorganic Chemistry, Columbia University. His work includes fundamental contributions to the field of chemistry as well as applied contributions in the areas of chemotherapy and vaccine development. Dr. Danishefsky has become the recognized international authority on the total synthesis of complex natural products. He has brought forth the most complex carbohydrate based anti-tumor vaccines which have ever been brought to clinical trial. Dr. Danishefsky has had a major influence on the pharmaceutical industry as a Consultant inventor, advisor, mentor and through his many students and post-doctoral fellows who now hold senior positions in the industry. He is widely recognized as a leader in the field of organic synthesis with particular emphasis in carbohydrate chemistry. He has a 40-year career in the synthetic chemistry of natural products. Dr. Danishefsky serves as a Member of Scientific Advisory Board of Acretia Inc. and Optimer Pharmaceuticals, Inc. He serves as a Member of Cancer Scientific Advisory Board of Progenics Pharmaceuticals Inc. He serves as a Member of Scientific Advisory Board of Kosan Biosciences Inc. He also serves as a Member of Scientific Advisory Board of Conforma Therapeutics Corporation and HerbalScience Singapore Pte, Ltd. He has been a Member of Scientific Advisory Board of Cellceutix Corporation since July 2009. Dr. Danishefsky served as a Member of Scientific Advisory Board of Nereus Pharmaceuticals Inc. Dr. Danishefsky serves as a Member of the Connecticut Academy of Science, the American Association for the Advancement of Science, the American Academy of Arts and Sciences and the National Academy of Sciences in 1985. Dr. Danishefsky spent 14 years at Yale University, where he rose to the rank of Sterling Professor of Chemistry, the highest academic rank at Yale University, awarded to a tenured faculty member considered one of the best in his field. Dr. Danishefsky accomplishments have been recognized with numerous awards and honors, including election to membership in the National Academy of Sciences. From the American Chemical Society he received the Ernest Guenther Award, the Aldrich Award for creative work in organic synthesis, and an A. Cope Scholar Award. In 1997, Dr. Danishefsky received the Claude S. Hudson Award in Carbohydrate Chemistry from the American Chemical Society, in 1998 the Arthur C. Cope Medal and in 1999 the Nichols Medal. He received the Ehrlich award from the French Pharmaceutical Society in 1998, National Academy of Science Award for Chemical Sciences in 2006, he Benjamin Franklin Medal in Chemistry from the Franklin Institute in Philadelphia (2006), the Bristol-Myers Squibb Distinguished Lifetime Achievement Award in Organic Synthesis (2006) and the Tetrahedron Prize in Chemistry in 1996. In 1996, Dr. Danishefsky shared the Wolf Prize in Chemistry with Professor Gilbert Stork. He was the 1997 Recipient of the Claude S. Hudson Award in Carbohydrate Chemistry from the American Chemical Society and also received the New York City Mayor's Award for Science and Technology. Dr. Danishefsky earned his BS degree from Yeshiva University and received his Ph.D. in chemistry from Harvard University and postdoctoral fellow from Columbia University
